24.22
前日終値:
$23.39
開ける:
$23.845
24時間の取引高:
10.04M
Relative Volume:
1.63
時価総額:
$12.10B
収益:
$4.89B
当期純損益:
$-242.00M
株価収益率:
-49.53
EPS:
-0.489
ネットキャッシュフロー:
$315.00M
1週間 パフォーマンス:
+0.71%
1か月 パフォーマンス:
+21.53%
6か月 パフォーマンス:
+9.64%
1年 パフォーマンス:
+81.70%
Elanco Animal Health Inc Stock (ELAN) Company Profile
名前
Elanco Animal Health Inc
セクター
電話
877-352-6261
住所
450 ELANCO CIRCLE, INDIANAPOLIS
Compare ELAN vs TAK, HLN, TEVA, ZTS, UTHR
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
ELAN
Elanco Animal Health Inc
|
24.22 | 11.68B | 4.89B | -242.00M | 315.00M | -0.489 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.63 | 48.72B | 29.91B | 1.30B | 3.49B | 0.4056 |
|
HLN
Haleon Plc Adr
|
8.96 | 39.16B | 14.54B | 2.22B | 2.58B | 0.4871 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
31.48 | 37.91B | 17.53B | 1.58B | 444.18M | 1.3457 |
|
ZTS
Zoetis Inc
|
78.71 | 32.39B | 9.51B | 2.64B | 2.14B | 6.0361 |
|
UTHR
United Therapeutics Corp
|
536.59 | 23.41B | 3.17B | 1.29B | 1.01B | 27.09 |
Elanco Animal Health Inc Stock (ELAN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-04-15 | 開始されました | Citigroup | Buy |
| 2026-01-22 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2025-12-09 | 開始されました | Barclays | Overweight |
| 2025-11-21 | 開始されました | KeyBanc Capital Markets | Overweight |
| 2025-11-19 | アップグレード | Argus | Hold → Buy |
| 2025-10-07 | アップグレード | JP Morgan | Neutral → Overweight |
| 2025-07-17 | アップグレード | Leerink Partners | Market Perform → Outperform |
| 2025-06-26 | アップグレード | William Blair | Mkt Perform → Outperform |
| 2024-12-09 | 開始されました | UBS | Buy |
| 2024-12-02 | 開始されました | Leerink Partners | Market Perform |
| 2024-09-19 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2024-01-05 | アップグレード | Stifel | Hold → Buy |
| 2023-12-19 | 開始されました | Jefferies | Buy |
| 2023-12-15 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2023-12-07 | 開始されました | Exane BNP Paribas | Outperform |
| 2023-04-20 | アップグレード | Barclays | Equal Weight → Overweight |
| 2022-08-18 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2022-08-16 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2022-07-21 | ダウングレード | Goldman | Buy → Sell |
| 2022-07-12 | 開始されました | Piper Sandler | Neutral |
| 2021-11-18 | 開始されました | Morgan Stanley | Overweight |
| 2021-10-28 | ダウングレード | Stifel | Buy → Hold |
| 2021-08-05 | 再開されました | Credit Suisse | Outperform |
| 2021-06-15 | アップグレード | Cleveland Research | Underperform → Neutral |
| 2021-05-11 | アップグレード | Barclays | Underweight → Equal Weight |
| 2021-05-11 | アップグレード | Gabelli & Co | Hold → Buy |
| 2021-04-15 | 開始されました | Stifel | Buy |
| 2021-03-22 | ダウングレード | Gabelli & Co | Buy → Hold |
| 2021-02-26 | アップグレード | Credit Suisse | Neutral → Outperform |
| 2020-12-09 | ダウングレード | Argus | Buy → Hold |
| 2020-11-09 | ダウングレード | Barclays | Overweight → Underweight |
| 2020-08-20 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2020-08-13 | 再開されました | Credit Suisse | Neutral |
| 2020-08-04 | 再開されました | Goldman | Buy |
| 2020-07-27 | ダウングレード | Cleveland Research | Neutral → Underperform |
| 2020-04-02 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2020-01-10 | 開始されました | Raymond James | Mkt Perform |
| 2019-12-19 | アップグレード | BofA/Merrill | Neutral → Buy |
| 2019-11-07 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2019-09-23 | 開始されました | Barclays | Overweight |
| 2019-08-26 | ダウングレード | BofA/Merrill | Buy → Neutral |
| 2019-08-15 | アップグレード | UBS | Sell → Neutral |
| 2019-05-23 | 開始されました | Guggenheim | Neutral |
| 2019-03-18 | アップグレード | BofA/Merrill | Neutral → Buy |
| 2019-03-13 | 再開されました | Morgan Stanley | Equal-Weight |
| 2019-02-12 | 開始されました | William Blair | Mkt Perform |
| 2019-01-23 | 開始されました | UBS | Sell |
| 2019-01-15 | 開始されました | Argus | Buy |
| 2018-10-15 | 開始されました | Morgan Stanley | Equal-Weight |
すべてを表示
Elanco Animal Health Inc (ELAN) 最新ニュース
Elanco Ventures Expands Animal Health Innovation Ecosystem - Kalkine Media
Veterinary API Manufacturing Market to Reach USD 18.48 Billion by 2035 as Animal Health Investments and Zoonotic Disease Prevention Accelerate – SNS Insider - GlobeNewswire Inc.
TD Cowen Issues Positive Forecast for Elanco Animal Health (NYSE:ELAN) Stock Price - MarketBeat
Elanco launches $25M VC program to invest in animal health innovation - Indianapolis Business Journal
Elanco Animal Health Incorporated Establishes Elanco Ventures Corporate Venture Capital Platform - marketscreener.com
Elanco plans VC platform to fast track animal health innovation - Feedstuffs
Elanco Animal Health Launches Venture Capital Platform - Intellectia AI
Elanco (ELAN) Launches Venture Capital Platform for Animal Healt - GuruFocus
Elanco bets $25 million on startup tech for animal health - Stock Titan
Elanco Animal Health Inc (ELAN) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Elanco Animal Health Inc (ELAN) Valuation: PE, PB & Fair Value Analysis - TradingKey
Elanco Animal Health Inc (ELAN) Institutional Confidence - TradingKey
Elanco Animal Health Inc (ELAN) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Elanco Animal Health Inc (ELAN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Elanco Animal Health Inc (ELAN) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
A Look at Elanco Animal Health Inc (ELAN) After 3.5% Decline -- GF Value $15.55 vs Price $23.39 - GuruFocus
ExodusPoint Capital Management LP Buys 491,617 Shares of Elanco Animal Health Incorporated $ELAN - MarketBeat
Elanco (ELAN) CFO VanHimbergen receives deferred stock unit grant under deferral plan - Stock Titan
Elanco (ELAN) CEO Jeffrey Simmons receives deferred stock unit grant - Stock Titan
Deferred stock award to Elanco (NYSE: ELAN) executive disclosed - Stock Titan
Elanco Animal Health Inc (ELAN) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Elanco CEO: Screwworm Easier To Manage Than Contain - marketscreener.com
Elanco Announces USDA Approval of TruCan™ Ultra Lyme-L4, the Fir - GuruFocus
9 New 4-Star Stocks This Week - Morningstar
Elanco (ELAN) Introduces TruCan Ultra Lyme-L4 Vaccine for Dogs - GuruFocus
Elanco receives USDA approval for canine combination vaccine By Investing.com - Investing.com Canada
New low-volume dog vaccine targets Lyme and leptospirosis in a single shot - Stock Titan
Elanco Animal Health Inc (ELAN) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Elanco Animal Health Incorporated $ELAN Position Reduced by Black Creek Investment Management Inc. - MarketBeat
Private Management Group Inc. Reduces Stake in Elanco Animal Health Incorporated $ELAN - MarketBeat
Elanco Animal Health Q1 earnings call highlights - MSN
Brandes Investment Partners LP Has $95.09 Million Position in Elanco Animal Health Incorporated $ELAN - MarketBeat
Elanco Animal Health Inc (ELAN) Shares Surge 3.5% -- What GF Sco - GuruFocus
Norges Bank Makes New $32.42 Million Investment in Elanco Animal Health Incorporated $ELAN - MarketBeat
Elanco Animal Health Incorporated $ELAN Shares Sold by Bank of New York Mellon Corp - MarketBeat
Elanco Animal Health (ELAN) Stock Analysis: A 26% Upside Potential in the Healthcare Sector - DirectorsTalk Interviews
Clearbridge Investments LLC Has $128.37 Million Stock Position in Elanco Animal Health Incorporated $ELAN - MarketBeat
Harvest Fund Management Co. Ltd Has $366,000 Stock Holdings in Elanco Animal Health Incorporated $ELAN - MarketBeat
TD Asset Management Inc Purchases 516,628 Shares of Elanco Animal Health Incorporated $ELAN - MarketBeat
Jim Cramer Recommends Elanco Over Zoetis - Insider Monkey
Is Elanco’s Big Rally Still Worth Watching After Its Sharp Climb? - Kalkine Media
Earnings call transcript: Elanco Animal Health Q1 2026 surpasses expectations with strong growth - Investing.com
Is It Too Late To Consider Elanco Animal Health (ELAN) After Its Strong 1 Year Rally? - Yahoo Finance
Elanco Animal Health Commits to Supporting U.S. Livestock Producers and Pet Owners in Fight Against New World Screwworm - CSRwire
Elanco offers treatments for New World screwworm in U.S. livestock By Investing.com - Investing.com Canada
Elanco Animal HealthOffers Treatment Options For Livestock And Pets Against New World Screwworm - TradingView
Elanco Animal Health Incorporated $ELAN Shares Bought by Bowen Hanes & Co. Inc. - MarketBeat
Elanco Animal Health Inc (ELAN) Stock Up 4.0% but GF Value Says Overvalued -- GF Score: 66/100 - GuruFocus
Survey: Pet owners maintain health spending despite rising costs - PetfoodIndustry
Jim Cramer Says He Feels 'Something Not Well' At Zoetis, Names A Rival As His Pick - Benzinga
U.S. pet owners cut dining out before pet care, Elanco finds - Stock Titan
Elanco Animal Health Inc (ELAN) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):